Job Description

Janssen \xe2\x80\x93 Senior Medical Advisor: Oncology

For more than 130 years, diversity, equity & inclusion (DEI) have been part of our cultural fabric at Johnson & Johnson and woven into how we do business every day. Our commitment to respect the dignity and diversity of all is embedded in our Credo. We know that the success of our business depends on having the best talent in a workforce that reflects the diverse markets we serve around the world and an inclusive culture that values different perspectives and life experiences That is why we in here in the UK, are working to create an inclusive environment where diverse backgrounds, perspectives and experiences are valued and each and every one of our people feels that they belong and can reach their potential. No matter who they are. Diversity, Equity & Inclusion at Johnson & Johnson means \xe2\x80\x9cYou Belong\xe2\x80\x9d!

The company

At Janssen, we are dedicated to addressing and solving some of the most unmet medical needs of our time in oncology, immunology, neuroscience, infectious diseases and vaccines, and cardiovascular and metabolic diseases. Driven by our dedication to patients, we bring innovative products, services and solutions to people throughout the world. Janssen is a company of Johnson & Johnson. Please visit www.janssen.co.uk for more information. Outstanding opportunity in UK based Janssen Growth Business - Oncology This is an exciting opportunity for a hard-working and focused high calibre Medical Affairs (MAF) professional to provide medical and scientific advice to the business, striving to make an immense difference to patients\xe2\x80\x99 lives in targeted unmet needs within Oncology conditions.

• The Medical Advisor will report to the Therapy Area Medical Lead and will play a meaningful role in providing support to the Oncology franchises, with a chance to create a difference to the therapy area. Janssen has a heritage in Oncology providing innovative treatments for people. To underline its dedication to these therapy areas, they have been designated as Disease Area Strongholds within Janssen, thereby ensuring that they receive focus in terms of pipeline development support and talent recruitment.
• To provide hybrid medical leadership in the development of the growing Oncology portfolio including current/future assets.
• In collaboration with Market Access function optimise market access and reimbursement for our assets by demonstrating scientific and evidence generation expertise internally and with external partners.
• To be a therapeutic area expert, responsible for engaging on a peer-to-peer basis with a defined audience of external Leading Specialists (LS) and indirectly via the Medical Science Liaison (MSL) team with the broader clinician base
• To evaluate all proposals for IISs against the global development strategy and be an advocate for the UK community

The Medial Advisor role will be a rewarding position involving work at all levels from outset for a commercial minded senior industry professional with a passion for medical affair activities. Janssen office-based positions are operated typically three days onsite and two days from \'home\' (i.e., flexi-working) at managers discretion

Core Functional Responsibilities, But Are Not Limited To

Therapy area knowledge:

• Have understanding of NHS issues affecting therapy area, including NHS priorities and market access issues/barriers.
• Understand how data sources contribute to the evidence generation plan.
• Help identify data gaps and propose a strategy to address them.
• Conduct literature searches, analyse clinical papers, attend conferences, courses, and other events to be abreast of the latest advances in relevant therapy areas.
• Identify evolving scientific concepts with future clinical implications

Customer excellence:

• Actively engage with key clinicians, academics and payers to build a keen awareness of customer needs and to utilise the insights to deliver projects that are mutually value adding.
• Exchange disease area knowledge and opinions in order to understand the emerging views on our products for early identification of key opportunities and barriers.
• Increase the customers\' understanding of our portfolio and to seek their advice on the development of our products.
• Handle and maintain positive relationship with leading Specialists.
• Understand the needs in evidence generation to support ongoing requirements of therapy area and product.

Evidence generation:

• Contribute to preparation and conduct of investigator meetings for company sponsored studies (CSS); recruitment follow-up and study result presentation.
• Align with R&D and GCO therapy area leads on trial site strategy for CSS.
• Be UK Lead for field-based Investigator Initiated Studies (ISS), Early Access Programs, or Real-World Evidence projects with MSL support.
• Lead field evidence generation projects through Global approval with support from wider oncology MSL team for further approval (PRP and Recap) and implementation.

Internal collaboration:

• Contribute to the development of the Oncology assets value Proposition in conjunction with traditional Integrated Brand Value Teams (IBVT) / Country Value Teams (CVT) roles, identifying and addressing data gaps to continually strengthen the value proposition.
• Familiar with NICE submissions and guidelines and drive value and support to health economic teams to gain health care reimbursement.
• Proactively engage EMEA/Global collaborators to ensure UK has a share of voice
• Utilise customer insights to give to cross-functional (marketing, medical, outcomes research, Business intelligence and communications) brand strategic and tactical plans.
• Maintain knowledge of all relevant local country specific differences, for example applicability of the ABPI Code of Practice in the UK, and the potential impact these differences may have on marketing a product, performing a clinical trial in the UK or holding an educational event there.
• Assist Medical Education Manager with delivery of aligned Medical Education projects as appropriate.

QUALIFICATIONS

Knowledge, Experience and Skills

• ABPI code of practice final signatory status is a pre-requisite.
• Qualified physician/pharmacist with post registration clinical experience (+5yrs) is preferred.
• Prior experience working in the field of Oncology is preferred.
• Commercially astute with good communication and negotiation skills whilst ensuring recognition and awareness of clinical reality and medical pragmatism.
• A very strong open, collaborative and leading ethical with a desire to succeed in the Medical Affairs environment.
• Excellent analytical skills, demonstrated by the ability to identify and understand sophisticated issues and problems, and interpret information in a manner that provides appropriate recommendations to senior leadership, marketing, and sales
• Familiar with NICE submissions and guidelines, and are passionate about growing access to our innovative medicines in the UK to patients with the highest unmet needs
• Comfortable working with local investigators on prospective clinical, HEOR and RWE studies.
• A proven track record to apply sophisticated scientific resources for presentations in a variety of different settings is required.
• Hands on work mentality, together with excellent Medical Affairs and preferably clinical development abilities.
• Strong teammate with the ability to empower others and succeed in a highly coordinated group environment.
• Able to travel to domestic and international scientific meetings.
• Must be fully cognizant of all relevant sophisticated scientific data and regulatory requirements for field-based personnel.
• Excels in building key relationships with key stakeholders; KOLs and Peers.
• Product launch experience
• May require up to 20-30% Travel

Johnson & Johnson is an Affirmative Action and Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, colour, religion, sex, sexual orientation, gender identity, age, national origin, or protected veteran status and will not be discriminated against on the basis of disability.